Orbis Allan Gray’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$53.6M Sell
183,191
-1,061,755
-85% -$349M 0.23% 64
2025
Q4
$436M Sell
1,244,946
-63,172
-5% -$21.3M 1.83% 21
2025
Q3
$423M Sell
1,308,118
-1,547,732
-54% -$481M 1.81% 21
2025
Q2
$1.11B Buy
2,855,850
+6,677
+0.2% +$2.69M 5.4% 3
2025
Q1
$1.24B Buy
2,849,173
+680,228
+31% +$273M 7.09% 3
2024
Q4
$800M Buy
2,168,945
+1,264,048
+140% +$529M 4.31% 5
2024
Q3
$471M Sell
904,897
-19,892
-2% -$10.6M 2.49% 12
2024
Q2
$501M Sell
924,789
-34,365
-4% -$18.2M 3.12% 8
2024
Q1
$497M Buy
959,154
+57,548
+6% +$28.6M 2.98% 11
2023
Q4
$425M Buy
901,606
+15,775
+2% +$7.29M 2.67% 13
2023
Q3
$386M Buy
885,831
+136,418
+18% +$61.9M 2.77% 13
2023
Q2
$333M Buy
749,413
+60,883
+9% +$28.1M 2.38% 17
2023
Q1
$317M Buy
688,530
+100,389
+17% +$47.8M 2.49% 15
2022
Q4
$302M Sell
588,141
-112,530
-16% -$57.1M 2.4% 19
2022
Q3
$318M Sell
700,671
-70,703
-9% -$33.8M 2.61% 17
2022
Q2
$372M Sell
771,374
-541,565
-41% -$268M 2.99% 14
2022
Q1
$645M Sell
1,312,939
-223,392
-15% -$102M 4.71% 5
2021
Q4
$712M Sell
1,536,331
-181,718
-11% -$76.4M 5.27% 5
2021
Q3
$640M Sell
1,718,049
-427,561
-20% -$162M 4.4% 6
2021
Q2
$819M Sell
2,145,610
-321,677
-13% -$123M 5.18% 4
2021
Q1
$886M Sell
2,467,287
-519,528
-17% -$167M 6.33% 3
2020
Q4
$959M Sell
2,986,815
-483,156
-14% -$148M 6.95% 3
2020
Q3
$932M Buy
3,469,971
+103,406
+3% +$27.8M 7.33% 3
2020
Q2
$885M Buy
3,366,565
+244,384
+8% +$65.2M 6.66% 4
2020
Q1
$709M Buy
3,122,181
+824,385
+36% +$225M 6.75% 4
2019
Q4
$694M Buy
2,297,796
+13,693
+0.6% +$3.77M 4.85% 5
2019
Q3
$548M Buy
2,284,103
+152,808
+7% +$41.9M 4.05% 8
2019
Q2
$601M Buy
2,131,295
+175,707
+9% +$48M 4.33% 7
2019
Q1
$561M Sell
1,955,588
-121,360
-6% -$35.1M 3.81% 7
2018
Q4
$545M Sell
2,076,948
-291,989
-12% -$80.3M 3.93% 9
2018
Q3
$649M Sell
2,368,937
-82,605
-3% -$21.4M 3.73% 10
2018
Q2
$584M Buy
2,451,542
+26,548
+1% +$6.15M 3.24% 11
2018
Q1
$533M Sell
2,424,994
-7,131
-0.3% -$1.68M 3.04% 12
2017
Q4
$547M Sell
2,432,125
-472,874
-16% -$101M 3.21% 14
2017
Q3
$552M Sell
2,904,999
-1,347,022
-32% -$256M 3.4% 10
2017
Q2
$800M Buy
4,252,021
+176,023
+4% +$31.6M 5.03% 5
2017
Q1
$674M Buy
4,075,998
+955,843
+31% +$152M 4.61% 4
2016
Q4
$449M Buy
3,120,155
+996,248
+47% +$133M 3.22% 10
2016
Q3
$266M Buy
2,123,907
+1,186,923
+127% +$153M 1.86% 15
2016
Q2
$123M Buy
936,984
+858,944
+1,101% +$118M 0.94% 28
2016
Q1
$10.8M Buy
+78,040
New +$10.4M 0.09% 65

Other funds holding ELV